IJE Advance Access originally published online on September 14, 2005
International Journal of Epidemiology 2005 34(5):1045-1046; doi:10.1093/ije/dyi165
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Published by Oxford University Press on behalf of the International Epidemiological Association © The Author 2005; all rights reserved.
Commentary |
Commentary: Smoking and atherosclerotic diseases in Asiathe implication in global atherosclerosis prevention
Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, People's Republic of China
* Corresponding author. Professor of Medicine and Therapeutics and Consultant Cardiologist, Prince of Wales Hospital, Shatin, Hong Kong SAR, People's Republic of China. E-mail: kamsangwoo@cuhk.edu.hk
| The first 10% of the full text of this article appears below. |
Atherosclerotic disease including stroke and coronary artery disease (CAD) is the most important health issue of modern society. Cigarette smoking has been associated with this disease in Western countries.1 In comparison, the impact of smoking on cardiovascular health has been less well documented in Asia, and, in particular, its impact in China where the population at risk currently comes up to one-quarter of the global population is unclear. Interest in the impact of smoking in China is inspired by the fact that although 70% of Chinese